TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Hospitalization for Heart Failure (HHF)
Endpoint domain: Mortality/survival
Primary endpoint: Rate of success in quitting tobacco
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 10-year cumulative CVD risk
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: experiential process measures
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Mean MADRS‐S score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: treatment linkage rates
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: acceptable clinical outcomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of social withdrawal
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dex‐Total concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Severe exacerbation rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Incidence of errors in material preparation, hand hygiene, and flushing and locking
Endpoint domain: Adverse events/effects
Primary endpoint: percentage of patients with severe pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: postoperative plasma acetaminophen levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Knowledge about influenza
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Intentions for vaccinations
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Reduction in occupational sitting
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Chest symptoms improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Respiratory muscle strength improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Tendon elasticity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Poor prognostic understanding regarding life expectancy estimates
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Discordance regarding life expectancy estimates
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: decision self-efficacy
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: perceived patient-physician interactions
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: patient-physician communication
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: 1-year infection rates
Endpoint domain: Adverse events/effects
Endpoint subdomain: Any subdomain
Primary endpoint: rate of PJI
Endpoint domain: Adverse events/effects
Endpoint subdomain: Any subdomain
Primary endpoint: 24 h MAGE
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: 24 h SD
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: 24 h CV
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: New HIV diagnosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Linkage to post-test services
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cost per HIVST kit distributed
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Recurrence prediction using NT-proBNP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Duration of flu-like symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in REU score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bucking incidence
Endpoint domain: Adverse events/effects
Primary endpoint: Pulmonary Embolism Quality of Life questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: EuroQol-5 Dimensions-3 Levels questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: self-reported stress perception
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: 2-step progression
Endpoint domain: Mortality/survival
Primary endpoint: 3-step progression
Endpoint domain: Mortality/survival
Primary endpoint: PDR (Proliferative Diabetic Retinopathy)
Endpoint domain: Mortality/survival
Primary endpoint: Mean length of delay for POP treatments
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: improved HRQOL
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Pain as measured with the VAS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative incidence of adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: PVC count fluctuation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Cmax and AUClast bioequivalence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Inhibition of DPP-4 activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of left ventricular diastolic dysfunction (LVDD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Prevalence of abnormal left ventricular longitudinal systolic strain (GLS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Prevalence of abnormal left atrial (LA) reservoir strain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Urinary levels of interleukin‐18 and kidney injury molecule‐1
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Serum level of interleukin‐10
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: NICU admissions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neonatal outcomes
Primary endpoint: Osteoporotic fracture risk
Endpoint domain: Mortality/survival
Primary endpoint: Any fracture risk
Endpoint domain: Mortality/survival
Primary endpoint: Time taken to perform surgical procedures
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Effective PIEB analgesia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: EI50 and EI90
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: executive functioning and memory improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change in appraisals of cognitive functioning
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: UTI symptom resolution
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Success of cannulation on the first attempt
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Caregiver's assessment of pain
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Utilization of infertility care
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: red cell transfusion requirements at 24 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: incidence of abnormal thromboelastographic measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Risk of severe symptoms in the maintenance phase
Endpoint domain: Adverse events/effects
Primary endpoint: mean BSL‐23 decline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Composite of mechanical ventilation, hospitalization for >14 days, or death
Endpoint domain: Mortality/survival
Primary endpoint: normalization of postvoid residual urine volumes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: reduction in incontinent episodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Death or moderate/severe CP by age 2
Endpoint domain: Mortality/survival
Primary endpoint: Birthweight below the third centile
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: increase in MVPA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ropivacaine dose per hour
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sputum-negative conversion rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Acceptance of the intervention
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Cosmetic outcome (CVAS score)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 44-joint disease activity score (DAS44)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: pain reactivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: IBS‐SSS total score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: abdominal pain intensity improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Seroconversion maintenance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Number of conscious people
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of systemic damage
Endpoint domain: Adverse events/effects
Primary endpoint: Progression of AKI to a higher stage
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: All-cause 28-d mortality
Endpoint domain: Mortality/survival
Primary endpoint: number of low-amplitude long distance propagating contractions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: number of high-amplitude propagating contractions (HAPCs)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: HAPCs amplitude
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Overall failure at 10-year follow-up
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Predictive ability for high-grade ccRCC
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: FACIT‐Sp change score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: QUAL‐E
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Compliance to IBD‐Home
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Increase in medical treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Preference for PrEP program
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: MG relapse rate
Endpoint domain: Adverse events/effects
Primary endpoint: FMA-LE (Fugl-Meyer Assessment for Lower Extremity)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean bacterial load for mutans streptococcus
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: mean bacterial levels of lactobacilli
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: perceived delivery sensation
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Reduction in nighttime systolic BP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Six-month safety
Endpoint domain: Adverse events/effects
Primary endpoint: Cardiovascular risk indices
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Negative subscale improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical Global Impressions‐Severity scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical Global Impressions‐Improvement scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Vomiting count
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: general satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: DMF scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Antibacterial activity against SM and LA counts
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of smoking filtered versus unfiltered cigarettes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Corrected QT interval (QTc) values
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: QT dispersion (QTd) values
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: posterior translational resistance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: posterior rotational stability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: safety outcomes (superficial SSI)
Endpoint domain: Adverse events/effects
Primary endpoint: safety outcomes (deep SSI)
Endpoint domain: Adverse events/effects
Primary endpoint: Closure success
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Permanent peripheral nerve injuries
Endpoint domain: Adverse events/effects
Primary endpoint: Ischaemic strokes
Endpoint domain: Adverse events/effects
Primary endpoint: Deglutition Handicap Index scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Functional Oral Intake Scale scores
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Motor aspects of MDS‐UPDRS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: discharge destination
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median suturing time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Accuracy of cup positioning
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Precision of cup positioning
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Percentage of cups within the safe zone
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Reduction in preoperative alcohol consumption
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Composite outcome of ischaemic stroke, major bleeding and all-cause mortality
Endpoint domain: Mortality/survival
Primary endpoint: Numeric rating scale score for postoperative pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to complete pain resolution
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Oral opioid morphine milligram equivalent
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality Adjusted Life Years (QALYs) gained
Endpoint domain: Mortality/survival
Primary endpoint: Diabetes-Free Days (DFD)
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: scores of physical health, social function, and mental health
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: VAS scores at 12 hours post-episiotomy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: VAS scores at 5 days post-episiotomy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety of 99mTc-TRODAT-1
Endpoint domain: Adverse events/effects
Primary endpoint: Mean cumulative urinary excretion over 24 h
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Absorbed dose in liver
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: symptom improvement following active iTBS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: FACE-Q values
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Weight management
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Incident ICH
Endpoint domain: Mortality/survival
Primary endpoint: HidroQoL total scale improvement
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: RAS-R score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Relief from anxiety
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Increased sense of personal agency
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Radical acceptance of anxiety
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Life Skills Improvement
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Work Productivity Improvement
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Estimated risk of falling
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: contamination rate
Endpoint domain: Adverse events/effects
Primary endpoint: Composite outcome of failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Glucose-insulin ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Primary outcome measurement
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Therapist competence (CTS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Depression (BDI‐II)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Therapeutic alliance (HAQ‐T/P)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increased positive attitudes toward HPV vaccination
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Increased intention to vaccinate
Endpoint domain: Life impact
Endpoint subdomain: Behavioral intentions
Primary endpoint: VAS scores of uterine contraction after analgesia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: sufentanil dosage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ropivacaine dosage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in ataxia severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Discrimination of malignancy potential
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: stage 2 or greater pelvic organ prolapse
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Death/MI at 1 year
Endpoint domain: Mortality/survival
Primary endpoint: Progression-Free Survival (PFS1)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Progression-Free Survival (PFS2)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AL elongation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: average and maximum speed
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: frequency of hemarthrosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: joint status
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: perceived joint pain
Endpoint domain: Life impact
Endpoint subdomain: Pain
Primary endpoint: composite endpoint
Endpoint domain: Mortality/survival
Primary endpoint: RDQ score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: ACT score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Weight loss maintenance ≥ 5% at Month 12
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Correct-to-incorrect rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: plasma retinol concentrations at 36 wk of gestation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: plasma retinol concentrations at 6 mo postpartum
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: milk retinol concentration at 6 mo postpartum
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Transversal skeletal increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dentoalveolar transverse diameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Width of the nasal floor
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diurnal tyrosine variations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Diurnal phenylalanine/tyrosine ratio variations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: skin barrier hydration improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: distance activities scores
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: peripheral vision scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total clinical efficacy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes